Blood Products Use in Bimaxillary Orthognathic Surgeries: A Retrospective Study by Eftekharian, Hamidreza et al.
Acad J Surg, Vol. 3, No. 1-2 (2016) ORIGINAL REPORT
Corresponding Author: Hamidreza Eftekharian 
Department of Oral and Maxillofacial Surgery, School of Dentistry, Shiraz University of Medical Sciences, Shiraz, Iran. 
Tel: +98 917 1114148/Fax: +98 71 36248980, E-mail: eftekharhr@sums.ac.ir 
http://ajs.tums.ac.ir 
Blood Products Use in Bimaxillary Orthognathic Surgeries: 
A Retrospective Study 
Hamidreza Eftekharian1, Shourangiz Dadain2, Ehsan Aliabadi3, Reza Tabrizi4
1 Associate Professor, Department of Anesthesiology AND Department of Oral and Maxillofacial Surgery, School of Dentistry, 
Shiraz University of Medical Sciences, Shiraz, Iran 
2 Under-graduate Student, Student Research Committee, School of Dentistry, Shiraz University of Medical Science, 
Shiraz, Iran 
3 Assistant Professor, Department of Craniomaxillofacial Surgery AND Department of Oral and Maxillofacial Surgery, School 
of Dentistry, Shiraz University of Medical Sciences, Shiraz, Iran 
Received: 22 Oct. 2015; Received in revised form: 16 Apr. 2016; Accepted: 10 Jul. 2016 
Abstract 
Background: The purpose of this study was to determine the consumption of blood products during 
orthognathic surgeries by age, sex, blood group, operation time, and the amount of blood loss. 
Methods: This is a retrospective cohort study. Patients who underwent bimaxillary osteotomy were studied. 
The study focused on types and amount of blood loss, blood products used, and change in patient’s hemoglobin 
(Hb) and hematocrit (HCT). Patients’ demographic data, blood type, and duration of surgery were variables of 
the research. 
Results: A total of 133 patients (52 males and 81 females) with a mean age of 22.950 ± 4.241 years formed the 
study population. Average blood loss was 556.32 ± 245.05 ml and the average operating time was 
259.96 ± 51.56 minutes. Results demonstrated that duration of the surgical and blood loss in males was higher 
than females. The mean of Hb and HCT levels before surgeries was 13.56 ± 1.30 and 40.47 ± 4.30, 
respectively, which significantly (P < 0.001) decreased to 11.969 ± 1.200 and 35.782 ± 3.800 1 day after the 
operations. The transfused blood products consisted of packed cells (5.4%), fresh frozen plasma (37.3%), and 
hydroxyethyl starch (57.3%). The percentage of patients who did not receive any transfusion was generally 
higher in the positive blood types than negative ones, with the highest percentage being in the AB+ group. 
Conclusions: A risk of using blood products particularly packed cells may increase if blood loss was above of 
800 ml and surgical duration more than 300 minutes. The duration of orthognathic surgery may have a 
significant effect on blood loss and blood transfusions. It seems subjects with positive blood types may have a 
lower risk for transfusion. 
© 2016 Tehran University of Medical Sciences. All right s reserved. 
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Introduction 
The need for blood transfusion during surgical 
operations has increased during recent decades due to 
the increased number and expansion of types of 
surgeries. Blood transfusion, if properly used, can be 
lifesaving. On the other hand, the precipitous increase 
in the use of blood products is considered as a serious 
problem to patients. 
Adequate and safe blood supply is one of the major 
concerns of contemporaneous health systems. Some 
initiatives have been done to reduce the potential 
hazards of blood transfusions to the lowest level. 
However, the irrational transfusions can still influence 
the prevalence of blood-borne infections. Even studies 
published in the past 10 years, during which excessive 
precautions have been taken in producing safe blood 
products, indicate a considerable risk of death (1,2) and 
an increase in the rate of post-operation infections as 
results of blood transfusion (2,3). Autotransfusion of 
the patient’s own blood (4) and use of blood and 
colloid solutions such as albumin, gelatin, dextran, 
hydroxyethyl starch (HES), and fresh frozen plasma 
(FFP) are considered as safer substitutes for hetero 
blood transfusion (5). Hetero blood transfusion is now 
suggested only to save lives, not for faster recovery (6). 
Orthognathic surgeries are often associated with 
blood loss. Blood cross matching routinely is 
performed for all patients undergoing such operations, 
in case excessive blood loss happens during operation. 
However, only a small proportion of patients 
undergoing these operations would really need blood 
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transfusion as human body can compensate a loss of up 
to 20% of blood (7). The risk of blood transfusion in 
orthognathic surgeries was controversial according to 
various reports. Samman et al. (8) indicated that single 
jaw operations and 63% of double jaw surgeries do not 
need blood transfusion. Flood et al. (9) also remarked 
that less than one-third of those undergone bimaxillary 
or sagittal split osteotomies surgeries required blood 
transfusion in their study. Moenning et al. (10) reported 
that only 4 out of 506 (< 1%) of bimaxillary surgery in 
their study needed blood transfusion. More recent 
studies indicate that even bimaxillary surgeries do not 
require blood transfusion in healthy adults (11,12) and 
that blood transfusions performed in many 
maxillofacial surgeries are unnecessary or in excess of 
actual required amount (13). 
The purpose of this study was to determine the 
consumption of blood products during orthognathic 
surgeries by age, sex, blood group, operation time, and 
the amount of blood loss. 
 
Materials and Methods 
This is a retrospective cohort study. Data from all 
patients undergone bimaxillary orthognathic surgery in 
Shahid-Chamran Hospital affiliated to Shiraz 
University of Medical Sciences, regardless of the 
reason for surgery, were used in this study. The study 
was performed from September 1, 2010, to October 31, 
2011. The research committee of the medical ethics 
group of Shiraz Medical Sciences University approved 
this study. The patients eligible for the study if they 
had maxillofacial deformity and undergone bimaxillary 
osteotomy and were in ASA 1 category. Those with 
bleeding problems, high blood pressure, recent history 
of taking anticoagulant medicine, allergy to anesthetic 
drugs, condition preventing the use of controlled 
hypotensive anesthesia, and recent history of smoking 
or use of opiates were excluded. 
All patients underwent hypotensive anesthesia. Pre-
operative patient assessment and selection, appropriate 
positioning and monitoring, and adequate fluid therapy 
are used for the patients undergoing induced 
hypotension during orthognathic surgery. Hypotensive 
anesthesia is corrected in relation to the patient’s pre-
operative blood pressure and be adjusted to the 
necessary level for blood loss reduction in the surgical 
field. A mean arterial blood pressure (MAP) 30% 
below a patient’s usual MAP. The anesthesiologists 
were blinded to the type of irrigation fluid. Anesthesia 
was induced with intravenous propofol 2 mg/kg and 
fentanyl 0.5 mcg/kg and was maintained using total 
intravenous anesthesia with propofol infusion 100 
mcg/kg and remifentanil 0.2-0.3 mic/kg/min. 
Atracurium 0.5 mg/kg was used for endotracheal 
intubation. Baseline hemoglobin (Hb) and hematocrit 
(HCT) were measured on the day before the surgery. 
Blood loss was measured according to the amount of 
blood (ml) accumulated in the suction canister at the 
end of the case, after subtracting the amount of 
irrigation fluid that was used intraoperatively. In 
addition, all pieces of 4 cm × 4 cm gauze were weighed 
at the end of the case and each one gram increase in the 
weight of the gauze was considered 1 ml blood loss. 
All pieces of gauze were kept in a Beex container to 
prevent evaporation of fluids and obtain an accurate 
estimation of blood loss. Total operative and 
hypotensive times were recorded for each patient. 
Similarly, blood product transfusion and the volume of 
irrigation solution used were recorded. 
Subject’s demographic data, blood type, patient’s 
Hb, and HCT before and 24 hours after surgery 
duration of surgery, blood loss, and the amount and 
type of blood products used were recorded. Blood 
products used in these surgeries consisted of packed 
red cells, FFP, and HES. 
The incision was made over the anterior portion of 
the vertical ramus, extending to the mesial aspect of the 
first molar. Subperiosteal dissection was carried out 
down to the inferior border of the mandible, where a 
lateral channel retractor was placed. A long bur was 
used to make a horizontal bone cut through the medial 
cortex of the ramus, just above, and approximately 
posterior to the lingula. The vertical cut was made 
through the buccal cortex, distal to the second molar or 
further anteriorly. The two osteotomies were then 
connected with a 701 fissure bur. The vestibular 
incision in maxilla was made from the first molar to the 
contralateral first molar. The superior tissues were 
reflected subperiosteally, first at the pyriform aperture 
margins. Then, lateral nasal and infraorbital regions 
were exposed and extended posteriorly to the 
zygomatic-maxillary buttress. Two internal reference 
points intraorally were marked to determine anterior-
posterior and vertical movements in each side of the 
maxilla. Osteotomy lines were made 5 mm superior to 
the apex of the teeth roots. After ending osteotomies 
and down fracture, maxilla was mobilized and 
positioned in the desirable position using an 
intermediate splint. Bone interferences were removed 
and maxilla was fixed using four miniplates. A 
spreader and a narrow osteotome were used to lift the 
lateral cortex of the sagittal osteotomy gently, and the 
osteotome was used to step along the connecting cut to 
ensure that the split stayed close to the lateral cortex. 
Finally, the mandible was positioned in the final position 
and the condyle was positioned manually by a superior 
and posterior pressure during fixation using a miniplate 
and monocortical screws in each osteotomy site. 
The statistical analyses were performed using SPSS 
for Windows (version 19; IBM Corp., Armonk, NY, 
USA). Independent t-test, paired t-test, z-test, chi-
square, bivariate correlation, and linear regression were 
used to analyze the data.  
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Results 
Among the 133 patients who had bimaxillary 
orthognathic surgery in Shahid-Chamran Hospital 
affiliated to Shiraz University of Medical Sciences, 
during the period of this study, 133 had the desired 
conditions to be included for data analysis. 61 (61%) of 
them were females and 52 (39%) were males. Their 
average age was 22.95 ± 4.24 years. 
The average operation time was 260 minutes. The 
operations took slightly longer for males (P = 0.012). 
In average, 556 ml blood was lost during each surgery 
(Table 1). Males lost markedly more blood than 
females (P < 0.001). The mean Hb and mean HCT of 
each patient 24 hours after surgery were, respectively, 
1.6 g/dl and 4.7% lower than those measured before 
surgery (Table 2). The falls in both Hb and HCT were 
statistically significant regardless of blood infusion  
(P < 0.001 for both). 
 
Table 1. Average operation time and blood loss by sex 
Operation time and 
blood loss 
Sex Average 
Operation time (min) Males 274.23 ± 53.66 
Females 250.80 ± 48.30 
All 259.96 ± 51.56 
Blood loss (ml) Males 703.85 ± 293.11 
Females 461.60 ± 145.19 
All 556.32 ± 245.05 
 
About 39 males (75.0% of males) and 37 females 
(45.7% of females) needed some sort of blood 
transfusion. No platelet was given. No one received 
packed cells alone. 10 patients (7.5% of all patients) 
were given only FFP with an average of 375 ml each. 
16 people (12.0% of all) received 531 ml HES in 
average. 40 patients (30.0%) received a mixture of two 
blood products. 10 patients needed the three types of 
blood product (packed cell). 
About 1375 ml blood product was transfused to 
each of the latter group, in which the number of males 
was significantly higher than females (P < 0.001). On 
the whole, an average of 803 ml blood was used for 
each patient that needed transfusion. The average 
transfused blood product decreased to 459 ml, when 
those who did not need any transfusion were included 
(Table 3). 
Among blood types, O+ and B+ were more 
frequent (41.4% and 21.8% respectively). No one was 
AB− and only a few patients had a blood type of A− or 
B−. The percentage of subjects who did not receive any 
transfusion was generally higher in the positive blood 
types than negative ones, with the highest percentage 
being in the AB+ group. Figure 1 compares the 
frequency of those who received each type of blood 
product within sexes and blood type groups. 
 
 
Figure 1. Frequency of blood products used within the two 
sexes and each type of blood 
 
The amount of transfused product was significantly 
correlated with duration of operation and blood loss  
(P < 0.001 for both). After adjustments, both 
correlations remained significant, although the P value 
for the duration of surgery increased to 0.008. The 
average of blood loss for those who received blood 
products during surgery (674.08 ± 258.35 ml) was 
significantly (P < 0.001) higher than those who did not 
receive any blood product (399.30 ± 90.77 ml). The 
average duration time of surgery in those who received 
blood products during surgery (283.55 ± 49.10 
minutes) was also significantly (P < 0.001) higher than 
those who did not receive any blood product  
(228.51 ± 35.70 minutes). The probability for the need 
for transfusion significantly increased in those who lost 
more than 800 ml blood and those whose operation 
took longer than 300 minutes (P < 0.001 for both). 
 
Table 2. Changes in Hb and HCT of blood of patients 24 hours after surgery comparing with those just before operation 
Hemoglobin and hematocrit Sex Before surgery After surgery Difference (Mean ± SD) 
Hb (g/dl) Males 14.65 ± 1.14 12.69 ± 1.18 −1.96 ± 0.99 
Females 12.86 ± 0.82 11.50 ± 0.92 −1.35 ± 0.59 
All 13.56 ± 1.30 11.97 ± 1.18 −1.59 ± 0.82 
HCT (%) Males 44.83 ± 3.03 38.93 ± 3.55 −5.90 ± 2.05 
Females 37.67 ± 2.22 33.76 ± 2.22 −3.90 ± 1.50 
All 40.47 ± 4.34 35.78 ± 3.78 −4.69 ± 1.99 
Hb: Hemoglobin; HCT: Hematocrit 
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Table 3. Number of males and females received blood products 
and average amount they received, by type of blood product 
Blood product Sex Number 
Average 
amount (ml) 
No transfusion 
needed 
Males 13 0 
Females 44 0 
Both sexes 57 0 
Packed cell Males 0 0 
Females 0 0 
Both sexes 0 0 
FFP Males 4 438 
Females 6 333 
Both sexes 10 375 
Platelet Males 0 0 
Females 0 0 
Both sexes 0 0 
HES Males 7 571 
Females 9 500 
Both sexes 16 531 
Two products 
(packed cell + 
FFP) 
Males 0 0 
Females 1 800 
Both sexes 1 800 
Two products 
(packed cell + 
HES) 
Males 0 0 
Females 0 0 
Both sexes 0 0 
Two products 
(FFP + HES) 
Males 20 875 
Females 19 881 
Both sexes 39 878 
Three products 
(packed cell + 
FFP + HES) 
Males 8 1456 
Females 2 1050 
Both sexes 10 1375 
HES: Hydroxyethyl starch; FFP: Fresh frozen plasma 
 
Discussion 
This study tried to address using blood products, which 
kind of, and how much in orthognathic surgeries. The 
results of this study confirm that blood transfusion is 
common during orthognathic surgeries due to the 
timely nature of these surgeries and usual massive 
blood loss. 
Our study was not an exception among similar 
studies and more than half of the subjects, who 
underwent bimaxillary surgery in our target hospital, 
were transfused. Flood et al. (9) in a study conducted, 
in 1990, stated that almost one-third of patients who 
underwent orthognathic bimaxillary surgery needed 
blood transfusions. Samman et al. (8) expressed in 
1996 that blood transfusions in a single jaw surgery is 
not necessary but is necessary in bimaxillary surgeries. 
Ash and Mercuri (14) mentioned that in 75% of 
bimaxillary surgeries transfusion is needed. The 
percentage is usually far lower in single jaw surgeries. 
Our findings are in line with findings of Moenning  
et al. (10), Ueki et al. (11), and Rummasak et al. (15), who 
all mentioned that the need for blood transfusions in their 
studies increases with increased blood loss during 
orthognathic surgery. Faverani et al. studied on  
45 subjects who underwent orthognathic surgeries .They 
reported only two subjects needed blood transfusion. 
However, there was a substantial individual variation in 
pre- and post-operative Hb values (16).
 
Despite the previous reports (8,9,14,17), Garg et al. 
(18) suggested grouping and saving blood with 
antibody or coagulation screening are not necessary 
before orthognathic operations in ASA Grade I patients 
who have no history of bleeding disorders or previous 
blood transfusion. A recent study showed no 
significant factor was associated with blood loss and 
reduced blood ingredients among patients in 
orthognathic surgery with hypotenstive anesthesia. 
Improvements in anesthesia provided surgeons with 
more time to promote hemostasis during surgery. 
Hypotensive anesthesia was a well-accepted method to 
reduce blood loss during orthognathic surgery (19). 
Another study concluded the factors that influence blood 
loss includes patient gender, experience of the surgeon, 
and operative time. Blood preparation should be 
considered in women, especially small individuals in 
whom a long operative time is expected and who are 
being operated on by an inexperienced surgeon. Because 
of the low rate of transfusion, a group-and-save policy is 
appropriate (15). It was demonstrated that type and screen 
testing and verification of ABO/Rh status seems to be an 
adequate precaution to manage blood loss. As severe 
hemorrhage that requires transfusion of allogeneic blood 
has become the exception rather than the rule in 
bimaxillary orthognathic operations (20). 
Pineiro-Aguilar et al. (21) emphasized that the 
intraoperative bleeding observed in patients during Le 
Fort I or mandibular ramus osteotomies or both 
combined was less than the limits set for blood 
transfusion. However, bleeding was occasionally 
heavier and surgeons should be prepared for heavier 
bleeding by reserving blood at a blood bank or by 
preparing an autotransfusion. Posnick et al. (22) 
suggested that only a small percentage (6%) of 
individuals undergoing complex orthognathic and 
intranasal surgery received blood replacement. We 
believe that close collaboration between the surgical 
and anesthesia teams and the recovery of patients in a 
safely monitored environment will continue to reduce 
the need for transfusion in the orthognathic patient. 
 
Conclusion 
The risk of using blood products particularly packed 
cells may increase if blood loss was above of 800 ml 
and duration of the surgery more than 300 minutes. 
The duration of orthognathic surgery may have a 
significant effect on blood loss and blood transfusions. 
It seems subjects with positive blood types may have a 
lower risk for transfusion. 
 
Conflict of Interests 
Authors have no conflict of interests. 
Blood Products Use in Bimaxillary Orthognathic Surgeries 
 
6    Acad J Surg, Vol. 3, No. 1-2 (2016) 
 
http://ajs.tums.ac.ir 
Acknowledgments 
This manuscript was extracted from the thesis written 
by Dr. Shourangiz Dadain. The authors would like to 
thank grateful for the maxillofacial nursing staff in 
Shahid-Chamran Hospital affiliated to Shiraz 
University of Medical Sciences for their cooperation. 
 
References 
1. Shander A, Fink A, Javidroozi M, Erhard J, Farmer SL, 
Corwin H, et al. Appropriateness of allogeneic red blood 
cell transfusion: the international consensus conference 
on transfusion outcomes. Transfus Med Rev. 2011; 25(3): 
232-46. 
2. Glance LG, Dick AW, Mukamel DB, Fleming FJ, Zollo 
RA, Wissler R, et al. Association between intraoperative 
blood transfusion and mortality and morbidity in patients 
undergoing noncardiac surgery. Anesthesiology. 2011; 
114(2): 283-92. 
3. Marik PE, Corwin HL. Efficacy of red blood cell 
transfusion in the critically ill: a systematic review of the 
literature. Crit Care Med. 2008; 36(9): 2667-74. 
4. Marciani RD, Dickson LG. Autologous transfusion in 
orthognathic surgery. J Oral Maxillofac Surg. 1985; 
43(3): 201-4. 
5. Metz J, McGrath KM, Copperchini ML, Haeusler M, 
Haysom HE, Gibson PR, et al. Appropriateness of 
transfusions of red cells, platelets and fresh frozen 
plasma. An audit in a tertiary care teaching hospital. Med 
J Aust. 1995; 162(11): 572-7. 
6. Dhariwal DK, Gibbons AJ, Kittur MA, Sugar AW. Blood 
transfusion requirements in bimaxillary osteotomies. Br J 
Oral Maxillofac Surg. 2004; 42(3): 231-5. 
7. Messmer K. Hemodilution--possibilities and safety 
aspects. Acta Anaesthesiol Scand Suppl. 1988; 89: 49-53. 
8. Samman N, Cheung LK, Tong AC, Tideman H. Blood 
loss and transfusion requirements in orthognatic surgery. 
J Oral Maxillofac Surg. 1996; 54(1): 21-4. 
9. Flood TR, Ilankovan V, Moos KF, el-Attar A. Cross-
match requirements in orthognathic surgery: an audit. Br 
J Oral Maxillofac Surg. 1990; 28(5): 292-4. 
10. Moenning JE, Bussard DA, Lapp TH, Garrison BT. 
Average blood loss and the risk of requiring perioperative 
blood transfusion in 506 orthognathic surgical 
procedures. J Oral Maxillofac Surg 1995; 53(8): 880-3. 
11. Ueki K, Marukawa K, Shimada M, Nakagawa K, 
Yamamoto E. The assessment of blood loss in 
orthognathic surgery for prognathia. J Oral Maxillofac 
Surg. 2005; 63(3): 350-4. 
12. Gong SG, Krishnan V, Waack D. Blood transfusions in 
bimaxillary orthognathic surgery: are they necessary? Int 
J Adult Orthodon Orthognath Surg. 2002; 17(4): 314-7. 
13. Nath A, Pogrel MA. Preoperative autologous blood 
donation for oral and maxillofacial surgery: an analysis of 
913 patients. J Oral Maxillofac Surg. 2005; 63(3): 347-9. 
14. Ash DC, Mercuri LG. The relationship between blood 
ordered and blood administered in orthognathic surgery: 
a retrospective study. J Oral Maxillofac Surg. 1985; 
43(12): 944-6. 
15. Rummasak D, Apipan B, Kaewpradup P. Factors that 
determine intraoperative blood loss in bimaxillary 
osteotomies and the need for preoperative blood preparation. 
J Oral Maxillofac Surg. 2011; 69(11): e456-e460. 
16. Faverani LP, Ramalho-Ferreira G, Fabris AL, Polo TO, 
Poli GH, Pastori CM, et al. Intraoperative blood loss and 
blood transfusion requirements in patients undergoing 
orthognathic surgery. Oral Maxillofac Surg. 2014; 18(3): 
305-10. 
17. Goodnough LT, Brecher ME, Kanter MH, AuBuchon JP. 
Transfusion medicine. First of two parts--blood 
transfusion. N Engl J Med. 1999; 340(6): 438-47. 
18. Garg M, Coleman M, Dhariwal DK. Are blood 
investigations, or group and save, required before 
orthognathic surgery? Br J Oral Maxillofac Surg. 2012; 
50(7): 611-3. 
19. Chen CM, Lai SS, Hsu KJ, Lee HE, Huang HL. 
Assessment of the related factors of blood loss and blood 
ingredients among patients under hypotensive anesthesia 
in orthognathic surgery. J Craniofac Surg. 2011; 22(5): 
1594-7. 
20. Fenner M, Kessler P, Holst S, Nkenke E, Neukam FW, 
Holst AI. Blood transfusion in bimaxillary orthognathic 
operations: need for testing of type and screen. Br J Oral 
Maxillofac Surg. 2009; 47(8): 612-5. 
21. Pineiro-Aguilar A, Somoza-Martin M, Gandara-Rey JM, 
Garcia-Garcia A. Blood loss in orthognathic surgery: a 
systematic review. J Oral Maxillofac Surg. 2011; 69(3): 
885-92. 
22. Posnick JC, Rabinovich A, Richardson DT. Blood 
replacement practices for complex orthognathic surgery: 
a single surgeon's experience. J Oral Maxillofac Surg. 
2010; 68(1): 54-9. 
 
